Investigation and comparison of antimullerin hormone in patients with tubal ectopic pregnancy treated with methotrexate and laparoscopy.
Phase 2
- Conditions
- Ectopic Pregnancy.Ectopic pregnancy
- Registration Number
- IRCT20240514061800N4
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Adult women 18-40 years old
Patients who do not have any relative or absolute contraindications for using methotrexate
Absence of liver failure
Not suffering from chronic renal failure with GFR less than 30 mL/min
No lung diseases, stomach ulcers and immune deficiencies
Exclusion Criteria
The patient's lack of consent to continue participating in the study
Incidence of complications related to methotrexate in the group treated with methotrexate
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the level of antimullerin hormone. Timepoint: Before, 3 and 6 months after the intervention. Method of measurement: Biochemical tests.
- Secondary Outcome Measures
Name Time Method